Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
meglumine (1 trial)
nitric oxide (inomax) (2 trials)
zonisamide (Zonegran) (1 trial)
Diabetic Foot (Phase 3)
Foot Ulcer (Phase 3)
Leishmaniasis (Phase 3)
Leishmaniasis, Cutaneous (Phase 3)
Trials (3 total)
Trial APIs (3 total)